SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-019363
Filing Date
2016-05-13
Accepted
2016-05-13 16:06:41
Documents
64
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crbp-10q_20160331.htm 10-Q 821157
2 EX-31.1 crbp-ex311_8.htm EX-31.1 17692
3 EX-31.2 crbp-ex312_6.htm EX-31.2 17730
4 EX-32.1 crbp-ex321_7.htm EX-32.1 8744
5 EX-32.2 crbp-ex322_9.htm EX-32.2 7577
  Complete submission text file 0001564590-16-019363.txt   4046481

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT crbp-20160331.xml EX-101.INS 844343
7 XBRL TAXONOMY EXTENSION SCHEMA crbp-20160331.xsd EX-101.SCH 42155
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crbp-20160331_cal.xml EX-101.CAL 38582
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crbp-20160331_def.xml EX-101.DEF 93742
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE crbp-20160331_lab.xml EX-101.LAB 280873
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crbp-20160331_pre.xml EX-101.PRE 218707
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37348 | Film No.: 161648383
SIC: 2834 Pharmaceutical Preparations